Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
  • WIIM
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Penny Stocks

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Small Cap

10 Biggest Price Target Changes For Monday

By Lisa Levin
Today, 8:30 AM
Needham raised OrthoPediatrics Corp. (NASDAQ: KIDS) price target from $70 to $77. Vertex Pharmaceuticals shares rose 0.2% to close at $63.51 on Friday.

CAR

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Long Ideas
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

EyeGate Pharma Stock Jumps On Initiation Of Proof Of Concept Trial With DHODH Inhibitor In Ophthalmology Indications

By Vandana Singh
Today, 8:30 AM
EyeGate Pharmaceuticals Inc (NASDAQ:EYEG) has dosed the patient in Phase 2 proof-of-concept study evaluating its lead product candidate, PP-001, in patients…

EYEG

Read More
4 minute read
  • Cannabis
  • Markets
  • Penny Stocks

Psyched: Atai’s $214M IPO, MindMed CEO Resigns, Field Trip Applies To Nasdaq, Cybin And Novamind Target Frontline Health Workers

By Natan Ponieman
Today, 8:30 AM
Atai Launches $214 Million Nasdaq IPO Offering Psychedelics biotech platform Atai life Sciences has announced an initial public offering of approximately 14 million of its common shares, ahead of the company’s expected Nasdaq listing.

CLXPF

Read More
1 minute read
  • Markets
  • Movers
  • Penny Stocks
  • Pre-Market Outlook

10 Communication Services Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights
Today, 8:30 AM
Gainers MediaCo Holding (NASDAQ: MDIA) stock rose 61.45% to $6.2 during Monday's pre-market session. The company's market cap stands at $48.6 million. 36KR Holdings (NASDAQ: KRKR) shares rose 5.83% to $2.54. The marketGainers

BAOS

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Long Ideas
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Why Is Enochian BioSciences (ENOB) Stock Surging Today?

By Vandana Singh
Today, 8:30 AM
The FDA has accepted Enochian BioSciences Inc’s (NASDAQ:ENOB) pre-IND (Investigational New Drug) request for a potential functional cure or treatment of…

ENOB

Read More
1 minute read
  • M&A
  • Media
  • News
  • Penny Stocks
  • Small Cap
  • Tech

Ideanomics Acquires EV Tractor Builder Solectrac For Undisclosed Sum

By Anusuya Lahiri
Today, 8:30 AM
Ideanomics Inc (NASDAQ:IDEX) had acquired premium zero-emission electric tractor manufacturer and distributor Solectrac Inc. The financial terms of the transaction remain…

IDEX

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Short Ideas
  • Trading Ideas

Avenue Therapeutics Pain Management Treatment Rejected By FDA Again; Shares Drop

By Vandana Singh
Today, 8:30 AM
Avenue Therapeutics Inc (NASDAQ:ATXI) has received a second Complete Response Letter from the FDA regarding its marketing application seeking approval for…

ATXI

Read More
2 minute read
  • Earnings
  • Eurozone
  • Futures
  • Global
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap

A Peek Into The Markets: US Stock Futures Edge Higher; Crude Oil Rises 1%

By Lisa Levin
Today, 8:30 AM
Pre-open movers

BBCP

Read More
3 minute read
  • Legal
  • News
  • Penny Stocks

Washington Prime Group Confirmed Late Sunday it is Commencing Voluntary Chapter 11 Financial Restructuring

By Charles Gross
Today, 8:30 AM
Washington Prime Group Inc. (NYSE: WPG) announced that it and certain of its subsidiaries have filed voluntary petitions for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court").

WPG

Read More
5 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

64 Biggest Movers From Friday

By Lisa Levin
Today, 8:30 AM
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share.

AEHL

Posts navigation

Previous 1 … 1,218 1,219 1,220 … 1,234 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service